Evidence map›Paper›PMID 25551772›Full record

ArticleCell cycle (Georgetown, Tex.)2015

Cell competition: winning out by losing notch.

Maria P Alcolea, Philip H Jones

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Outcompeting cancer.Nature reviews. Cancer · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Maria P Alcoleaa MRC Cancer Unit; University of Cambridge; Hutchison/MRC Research Center; Cambridge Biomedical Campus ; Cambridge , UK.
Philip H Jones
Hutchison/MRC Research Centre · GBMRC Cancer Unit · GB

Funding

Cancer Research UK 17257Cancer Research UK C609/A17257Medical Research Council MC_UU_12022/3Wellcome Trust WT090334MA
6 · The paper itself

Abstract

Cell competition where 'loser' cells are eliminated by neighbors with higher fitness is a widespread phenomenon in development. However, a growing body of evidence argues cells with somatic mutations compete with their wild type counterparts in the earliest stages of cancer development. Recent studies have begun to shed light on the molecular and cellular mechanisms that alter the competitiveness of cells carrying somatic mutations in adult tissues. Cells with a 'winner' phenotype create clones which may expand into extensive fields of mutant cells within normal appearing epithelium, favoring the accumulation of further genetic alterations and the evolution of cancer. Here we focus on how mutations which disrupt the Notch signaling pathway confer a 'super competitor' status on cells in squamous epithelia and consider the broader implications for cancer evolution.

Indexed as

AnimalsCell DifferentiationDNA-Binding ProteinsEpithelial CellsEsophagusMiceMutationNuclear ProteinsReceptors, NotchSignal TransductionTranscription FactorsTumor Suppressor Protein p53DNA-Binding ProteinsMaml1 protein, mouseNuclear ProteinsReceptors, NotchTranscription FactorsTumor Suppressor Protein p53cancercarcinogenesisDD, Cell division producing 2 differentiated cellsDN-Maml1, Dominant negative mutant of Mastermind like 1EE, Esophageal EpitheliumesophagusEYFP, Enhanced Yellow Fluorescent Proteinfield changeGFP, Green Fluorescent proteinNicd, Notch Cytoplasmic DomainPD, Cell division producing one progenitor and one differentiating cellPP, Cell division producing 2 progenitor cellsprogenitorsquamousstem cell

Identifiers

PMID25551772
PMCPMC4352972
OpenAlexW1968683224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.